Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by GenericAdvocateon Mar 22, 2017 10:35am
208 Views
Post# 26013404

RE:4 mysterious generics??? Alan shows openness....JMO

RE:4 mysterious generics??? Alan shows openness....JMOhappyretirement,  Latti may have something here as billy kenber wrote about Tazadone in this article


https://www.thetimes.co.uk/article/duplicate-permits-let-manufacturers-keep-their-dominance-fsrkp3lnq https://www.thetimes.co.uk/article/duplicate-permits-let-manufacturers-keep-their-dominance-fsrkp3lnq

You need a subscription to read the article but it said that Concordia bought a licence from Sharma for Trazadone and they already owned the drug so it does raise the question of anti-competitive cartel behavior.  I agree to a sense that the drugs are mysterious because I found it strange that they didn't give in their press release their brand names of the other drugs they bought or, more importantly, WHO they bought them from!   Especially since they are accused of stripping the brand names of products they bought from AMCo just to jack up prices.

 Another CMA investigation? ... that could be ...   I'm sure we will find out soon as the authorities in the UK certainly seem to work faster than authorities in the US ..

happyretirement wrote:
"earnout payment on the 4 mysterious generics they bought in July 2016 that "they can't talk about"  (these drugs will be what I anticipate will be the 3rd CMA investigation)"

"These products include Sodium Feredetate oral solution for the treatment of anemia, Trazadone oral solution for the treatment of depression, as well as two additional pipeline products".

On June 1, 2016, the Corporation announced that it had completed the acquisition of the global rights to four generic products through certain of its wholly-owned subsidiaries.

These products include Sodium Feredetate oral solution for the treatment of
anemia, Trazadone oral solution for the treatment of depression and antihistamine Alimemazine oral solution and tablets.

The
Corporation paid £ 21 for the acquisition with cash on hand. In addition, during the first quarter of 2017, the Corporation made £ 7 million in earn-out payments, as certain performance and supply targets were achieved.


 



<< Previous
Bullboard Posts
Next >>